Preclinical studies have demonstrated that the use of PROTAC in HNSCC cell lines have some anti-tumor effect in causing the loss of colony-forming abilities by degrading leucine zipper-bearing kinase (LZK), a protein that encourages HNSCC growth and proliferation [94]. The gene discussed is MAP3K13; the disease is neoplasm.